Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease

Angenendt Linus; Kerkhoff Andrea; Wiebe Stefanie; Mikesch Jan-Henrik; Rudat Annika; Woetzel Fabian; Wenning Christian; Schliemann Christoph; Kessler Torsten; Schaefers Michael; Wardelmann Eva; Stelljes Matthias; Berdel Wolfgang E.

首页> 外文期刊>Annals of hematology >Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease

【24h】

Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease

机译：严重特发性多中心Castleman病患者接受利妥昔单抗，托珠单抗和利妥昔单抗以及同种异体干细胞移植后不同质量的缓解

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of hematology 》 |2015年第7期| 共3页
作者
Angenendt Linus; Kerkhoff Andrea; Wiebe Stefanie; Mikesch Jan-Henrik; Rudat Annika; Woetzel Fabian; Wenning Christian; Schliemann Christoph; Kessler Torsten; Schaefers Michael; Wardelmann Eva; Stelljes Matthias; Berdel Wolfgang E.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease [J] . Angenendt Linus, Kerkhoff Andrea, Wiebe Stefanie, Annals of hematology . 2015 ,第7期

机译：严重特发性多中心Castleman病患者接受利妥昔单抗，托珠单抗和利妥昔单抗以及同种异体干细胞移植后不同质量的缓解
2. Complete remission in 4 patients with human herpesvirus 8-associated multicentric castleman disease using rituximab and liposomal doxorubicin, a Novel chemotherapy combination [J] . PekerD., MartinezA.E., SchwartzM.A., Clinical advances in hematology & oncology: H&O . 2012 ,第3期

机译：使用利妥昔单抗和阿霉素脂质体（一种新型化疗药物）联合治疗4例人类疱疹病毒8相关的多中心城堡病患者的完全缓解
3. Development of Kaposi's sarcoma after complete remission of multicentric Castlemans disease with rituximab therapy in a HHV8-positive, HIV-negative patient. [J] . Law AB, Ryan G, Lade S, International journal of hematology . 2010 ,第2期

机译：在HHV8阳性，HIV阴性的患者中，利妥昔单抗治疗完全缓解了多中心性Castlemans病后，卡波济肉瘤的发展。
4. HIGH-DOSE MELPHALAN CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN 65 PATIENTS WITH AL AMYLOIDOSIS: ORGAN PROGRESSION CAN BE DELAYED IN PATIENTS REACHING COMPLETE REMISSION [C] . SO Schonland, J.B Dengler, M Hundemer, International Symposium on Amyloidosis . 2008

机译：在65例Al淀粉样蛋白患者中，具有自体蛋白化疗的高剂量蛋白化疗：器官进展可以延迟达到完全缓解的患者
5. Symptoms, Cytokines, and Quality of Life of Patients with Chronic Graft-versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation. [D] . Kelly, Debra Lynch. 2014

机译：异基因造血干细胞移植后慢性移植物抗宿主病患者的症状，细胞因子和生活质量。
6. Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) [O] . Thomas Uldrick, Mark Polizzotto, Deirdre O’Mahony, 2010

机译：利妥昔单抗联合脂质体阿霉素（R-Dox）治疗HIV感染的严重卡波西肉瘤相关疱疹病毒（KSHV）相关的多中心Castleman病（MCD）患者
7. Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) [O] . Tosato Giovanna, Whitby Denise, Marshall Vickie, 2010

机译：利妥昔单抗联合脂质体阿霉素（R-Dox）治疗HIV感染的严重卡波西肉瘤相关疱疹病毒（KSHV）相关的多中心Castleman病（MCD）患者

Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman's disease

著录项

相似文献

相关主题

期刊订阅